177 related articles for article (PubMed ID: 17078187)
1. Control of hypertension in patients with peripheral artery disease.
Clement DL
Blood Press; 2006; 15(4):251-2. PubMed ID: 17078187
[No Abstract] [Full Text] [Related]
2. Intermittent claudication: a plea for guidelines for medical management.
Powell JT
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
[No Abstract] [Full Text] [Related]
3. Anti-platelet therapy: is it all over in peripheral artery disease?
Jaipersad AS; Silverman SH; Lip GY
Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
[No Abstract] [Full Text] [Related]
4. Peripheral arterial disease.
Hiatt WR; Nehler MR
Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
[No Abstract] [Full Text] [Related]
5. Intermittent claudication.
Emmerich J; Messas E; Fiessinger JN
N Engl J Med; 2007 Jul; 357(1):91-2; author reply 92-3. PubMed ID: 17611216
[No Abstract] [Full Text] [Related]
6. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
Singer DR; Kite A
Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
[TBL] [Abstract][Full Text] [Related]
7. How many claudicants should be prescribed statins?
Harrison EM; Holdsworth RJ
Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
[No Abstract] [Full Text] [Related]
8. Painful legs, aching heart: Reducing cardiovascular risk in patients with peripheral arterial disease with angiotensin-converting enzyme inhibition.
Gupta MK; Verma S
Can J Cardiol; 2005 Feb; 21(2):194-5. PubMed ID: 15729422
[No Abstract] [Full Text] [Related]
9. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
10. Buflomedil in peripheral arterial disease: trials and tribulations.
Conte MS
Circulation; 2008 Feb; 117(6):717-9. PubMed ID: 18268159
[No Abstract] [Full Text] [Related]
11. [Beta-adrenergic blockade and peripheral arterial insufficiency].
Sørlie D
Tidsskr Nor Laegeforen; 1995 Feb; 115(6):696-7. PubMed ID: 7900127
[No Abstract] [Full Text] [Related]
12. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
13. [Thrombosis and antithrombotic agents in peripheral artery disease].
Emmerich J
Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():59-62. PubMed ID: 12500607
[TBL] [Abstract][Full Text] [Related]
14. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
15. Endothelial dysfunction and the promise of ACE inhibitors.
Rockett JL
Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
[No Abstract] [Full Text] [Related]
16. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
Pierson CA; Epstein BJ; Roberts ME
J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336
[No Abstract] [Full Text] [Related]
17. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
De Backer TL; Vander Stichele RH; Van Bortel LM
Circulation; 2008 Sep; 118(10):e151. PubMed ID: 18765384
[No Abstract] [Full Text] [Related]
18. Hypertension in peripheral arterial disease.
Clement DL; De Buyzere ML; Duprez DA
Curr Pharm Des; 2004; 10(29):3615-20. PubMed ID: 15579058
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk in patients with peripheral vascular diseases.
Stoica A; Ginghină C
Rom J Intern Med; 2008; 46(4):275-83. PubMed ID: 19480293
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
